The predictive value of Lp(a) combined with Lp‐PLA2 for MACE in the target population was significantly improved, suggesting that Lp(a) combined with Lp‐PLA2 can serve as a superior indicator for assessing long‐term stroke recurrence risk in AIS patients. This evidence concerns the gene LPA and androgen insensitivity syndrome.